$11.19
At close: Jun 26 EDT
$10.66
-0.53-4.74%
Pre-Market: 8:30 AM EDT
Comments
Loading...
CERo Therapeutics Hldgs Analyst Ratings and Price Targets | NASDAQ:CERO | Benzinga
CERo Therapeutics Holdings Inc has a consensus price target of $16.5 based on the ratings of 2 analysts. The high is $30 issued by D. Boral Capital on June 24, 2025. The low is $3 issued by Maxim Group on May 19, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital, D. Boral Capital, and Maxim Group on June 24, 2025, June 23, 2025, and May 19, 2025, respectively. With an average price target of $21 between D. Boral Capital, D. Boral Capital, and Maxim Group, there's an implied 97.00% upside for CERo Therapeutics Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
Maxim Group
1calculated from analyst ratings
Analyst Ratings for CERo Therapeutics Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2025 | Buy Now | 181.43% | D. Boral Capital | Jason Kolbert50% | $30 → $30 | Maintains | Buy | Get Alert |
| 06/23/2025 | Buy Now | 181.43% | D. Boral Capital | Jason Kolbert50% | → $30 | Upgrade | Hold → Buy | Get Alert |
| 05/30/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert50% | — | Downgrade | Buy → Hold | Get Alert |
| 05/19/2025 | Buy Now | -71.86% | Maxim Group | Jason McCarthy41% | → $3 | Initiates | → Buy | Get Alert |
| 04/25/2025 | Buy Now | 3.19% | D. Boral Capital | Jason Kolbert50% | $11 → $11 | Maintains | Buy | Get Alert |
| 04/23/2025 | Buy Now | 3.19% | D. Boral Capital | Jason Kolbert50% | $11 → $11 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 3.19% | D. Boral Capital | Jason Kolbert50% | → $11 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for CERo Therapeutics Hldgs (CERO) stock?
The latest price target for CERo Therapeutics Hldgs (NASDAQ:CERO) was reported by D. Boral Capital on June 24, 2025. The analyst firm set a price target for $30.00 expecting CERO to rise to within 12 months (a possible 181.43% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CERo Therapeutics Hldgs (CERO)?
The latest analyst rating for CERo Therapeutics Hldgs (NASDAQ:CERO) was provided by D. Boral Capital, and CERo Therapeutics Hldgs maintained their buy rating.
When was the last upgrade for CERo Therapeutics Hldgs (CERO)?
The last upgrade for CERo Therapeutics Holdings Inc happened on June 23, 2025 when D. Boral Capital raised their price target to $30. D. Boral Capital previously had a hold for CERo Therapeutics Holdings Inc.
When was the last downgrade for CERo Therapeutics Hldgs (CERO)?
The last downgrade for CERo Therapeutics Holdings Inc happened on May 30, 2025 when D. Boral Capital changed their price target from N/A to N/A for CERo Therapeutics Holdings Inc.
When is the next analyst rating going to be posted or updated for CERo Therapeutics Hldgs (CERO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CERo Therapeutics Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CERo Therapeutics Hldgs was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.
Is the Analyst Rating CERo Therapeutics Hldgs (CERO) correct?
While ratings are subjective and will change, the latest CERo Therapeutics Hldgs (CERO) rating was a maintained with a price target of $30.00 to $30.00. The current price CERo Therapeutics Hldgs (CERO) is trading at is $10.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
